GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Evidence-Based Pharmacovigilance (Record no. 5298)

MARC details
000 -LEADER
fixed length control field 03673nam a22004455i 4500
001 - CONTROL NUMBER
control field 978-1-4939-8818-1
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610083626.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 181025s2018 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781493988181
-- 978-1-4939-8818-1
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-4939-8818-1
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM300-666
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMG
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MKG
Source thema
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615
Edition information 23
245 10 - TITLE STATEMENT
Title Evidence-Based Pharmacovigilance
Medium [electronic resource] :
Remainder of title Clinical and Quantitative Aspects /
Statement of responsibility, etc. edited by Andrew Bate.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2018.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York, NY :
Name of producer, publisher, distributor, manufacturer Springer New York :
-- Imprint: Humana,
Date of production, publication, distribution, manufacture, or copyright notice 2018.
300 ## - online resource
Extent XV, 275 p. 36 illus., 27 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in Pharmacology and Toxicology,
International Standard Serial Number 1940-6053
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Congenital Malformations -- Pharmacovigilance and the Eye -- Pharmacovigilance of Herbal and Traditional Medicines -- Pediatric Pharmacovigilance: Current Practice and Future Perspectives -- Detecting Safety Issues in Clinical Trials -- Developments and Future Directions of Prescription-Based Observational Cohort Pharmacovigilance -- Electronic Health Record, Transactional Insurance Claims, and Distributed Databases in Pharmacovigilance -- Patient Registries for Safetyness -- Patient-Reported Outcomes in Pharmacovigilance -- Evidence-Based Pharmacovigilance for Medicines Used in Public Health Programs in Africa -- Pharmacoepidemiological Approaches for Population-Based Hypothesis Testing -- Risk Management and Minimization -- Benefit-Risk Assessment in Pharmacovigilance -- Concluding Thoughts.
520 ## - SUMMARY, ETC.
Summary, etc. This book examines insights into the latest thinking and core concepts in areas of key methodological endeavor in Pharmacovigilance (PV), which strives to ever more effectively protect patients from harm caused by the medicines they need. Each book chapter tends to have a clear quantitative or clinical slant and an aim to provide an overview of methodological insights within a specific topic, while also providing a perspective on how the area is anticipated to develop in the future. Quantitative chapters focus more on statistical and epidemiological strategies and the thinking that underpins core developments in Pharmacovigilance, whereas clinical chapters focus on clinical methods for detecting hypotheses for and determining side effects of medicinal products as well as misdiagnosis pitfalls. Examples of areas of importance include signal detection, risk management, and risk benefit assessment. Vital and authoritative, Evidence-Based Pharmacovigilance: Clinical and Quantitative Aspects aims to provide readers with a sense of the advances that have occurred in pharmacovigilance methods and approaches, as well as inspiration and motivation to advance the field of pharmacovigilance with a strong sense that there is much more work to be done in ensuring the safe use of medications by patients.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bate, Andrew.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer Nature eBook
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781493988167
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781493988174
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in Pharmacology and Toxicology,
International Standard Serial Number 1940-6053
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-1-4939-8818-1">https://doi.org/10.1007/978-1-4939-8818-1</a>
912 ## -
-- ZDB-2-PRO

No items available.